Clinical Microbiology Newsletter
Volume 31, Issue 19 , Pages 145-150, 1 October 2009

The Laboratory's Role in Evaluating Sexually Transmitted Diseases as a Result of Sexual Abuse

  • Robert L. Sautter, Ph.D.

      Affiliations

    • Microbiology Laboratories, Carolinas Pathology Group, Carolinas Medical Center and Mecklenburg County Health Department, Charlotte, North Carolina
    • Corresponding Author InformationCorresponding Author: Robert L. Sautter, Ph.D., Director of Microbiology, Carolinas Pathology Group, Carolinas Laboratory Network, Department of Microbiology, Carolinas Medical Center, Charlotte, NC 28203. Tel.: 704-355-3476. Fax: 704-355-2156
  • ,
  • William D. LeBar, M.S.

      Affiliations

    • Microbiology and Virology Laboratories, University of Michigan Health System, Ann Arbor, Michigan
  • ,
  • Earl Greenwald, M.D.

      Affiliations

    • Children's Resource Center, Pinnacle Health System, Harrisburg, Pennsylvania

Abstract 

The microbiology laboratory is involved in the evaluation of patients for presumed sexual abuse when children are examined for the presence of a sexually transmitted disease (STD). Cultures for Chlamydia trachomatis and Neisseria gonorrhoeae are currently used as the forensic standard when sexual abuse is suspected. Culture methods for both of these agents are insensitive in this patient population and may require invasive sampling for adequate specimen collection. Until recently, the utility of nucleic acid amplification tests in the evaluation of children who might have been sexually abused has not been adequately evaluated. The sensitivity of these assays also allows them to be performed with non-invasive sample types, such as urine and vaginal specimens. This article reviews the performance of molecular assays for the diagnosis of common sexually transmitted infections associated with child abuse.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0196-4399(09)00043-9

doi:10.1016/j.clinmicnews.2009.09.001

Clinical Microbiology Newsletter
Volume 31, Issue 19 , Pages 145-150, 1 October 2009